http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23761421

Outgoing Links

Predicate Object
contentType Letter|Research Support, Non-U.S. Gov't
endingPage 224
issn 1465-3249
issueIdentifier 3
pageRange 223-224
publicationName Cytotherapy
startingPage 223
bibliographicCitation Halpenny M, William N, Elmoazzen H, Giulivi A, Martin L, Perron D, Bredeson C, Hamelin L, Huebsch L, Yang L, Birch P, Acker JP. The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation. Cytotherapy. 2022 Mar;24(3):223–4. doi: 10.1016/j.jcyt.2021.09.006. PMID: 34688545.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d16b7fabd41bf0dea33e32861733dba0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9644-7223
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_485be2b1b636ac22f807427fd6f7e3a7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e3dd5c1b6a77d2e138de37e8b312bd66
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ba712cc8518dc88f88eee1ed4bce733
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9ef26fbd62c6325926f0028d6b0bc6a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7bd0e899c66e14e32f0393ed558949fe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b10915b10e52e3f2d6521887352a268
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1445-827X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70dfc654be6c5d2e5db0d2741445f7bc
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_506edf282b8727eeaa879c431a2af204
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc
date 202203
identifier https://doi.org/10.1016/j.jcyt.2021.09.006
https://pubmed.ncbi.nlm.nih.gov/34688545
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/27065
https://portal.issn.org/resource/ISSN/1465-3249
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation

Total number of triples: 29.